Sanofi (SNY) receives FDA approval for Auvi-Q for the emergency treatment of people who suffer severe allergic reactions, such as to nuts and insect bites. The product is an auto-injector "that talks users through each step" of the process. Sanofi has licensed the rights in N. America from Intelliject, which retains commercialization rights for the rest of the world. (PR)
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at MarketWatch.com (Feb 19, 2015)
at Benzinga.com (Feb 5, 2015)
at Benzinga.com (Jan 15, 2015)
at CNBC.com (Jan 9, 2015)
at Investor's Business Daily (Jan 8, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs